These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26514310)

  • 1. Synthetic Cannabinoids and Their Effects on the Cardiovascular System.
    Von Der Haar J; Talebi S; Ghobadi F; Singh S; Chirurgi R; Rajeswari P; Kalantari H; Hassen GW
    J Emerg Med; 2016 Feb; 50(2):258-62. PubMed ID: 26514310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and Treatment of Patients with Clinical Illness Due to Synthetic Cannabinoid Inhalation Reported by Medical Toxicologists: A ToxIC Database Study.
    Monte AA; Calello DP; Gerona RR; Hamad E; Campleman SL; Brent J; Wax P; Carlson RG;
    J Med Toxicol; 2017 Jun; 13(2):146-152. PubMed ID: 28397128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation following synthetic cannabinoid abuse.
    Efe TH; Felekoglu MA; Çimen T; Doğan M
    Turk Kardiyol Dern Ars; 2017 Jun; 45(4):362-364. PubMed ID: 28595208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid drug use as a cause or contributory cause of death.
    Labay LM; Caruso JL; Gilson TP; Phipps RJ; Knight LD; Lemos NP; McIntyre IM; Stoppacher R; Tormos LM; Wiens AL; Williams E; Logan BK
    Forensic Sci Int; 2016 Mar; 260():31-39. PubMed ID: 26795398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Predictors of Synthetic Cannabinoid Use in Adolescents.
    Ninnemann AL; Jeong Choi H; Stuart GL; Temple JR
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28289139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids - Anchorage, Alaska, 2015-2016.
    Springer YP; Gerona R; Scheunemann E; Shafer SL; Lin T; Banister SD; Cooper MP; Castrodale LJ; Levy M; Butler JC; McLaughlin JB
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(40):1108-1111. PubMed ID: 27736839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
    Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
    JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How much can synthetic cannabinoid damage the heart? A case of cardiogenic shock following resistant ventricular fibrillation after synthetic cannabinoid use.
    Yamanoglu A; Celebi Yamanoglu NG; Evran T; Sogut O
    J Clin Ultrasound; 2018 Nov; 46(9):605-609. PubMed ID: 29479764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids and synthetic cannabinoids as a cause of death: Trends and their healthcare implications.
    Suriaga A; Tappen RM; Aston ER; Chiang-Hanisko L; Newman D
    J Nurs Scholarsh; 2023 May; 55(3):623-636. PubMed ID: 36250599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular effects of cannabinoids].
    Járai Z; Kúnos G
    Orv Hetil; 2002 Jun; 143(26):1563-8. PubMed ID: 12140859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole.
    Lindström E; Farde L; Eberhard J; Haverkamp W
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):615-29. PubMed ID: 15963244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample.
    Winstock A; Lynskey M; Borschmann R; Waldron J
    J Psychopharmacol; 2015 Jun; 29(6):698-703. PubMed ID: 25759401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cannabinoid withdrawal: a new demand on detoxification services.
    Macfarlane V; Christie G
    Drug Alcohol Rev; 2015 Mar; 34(2):147-53. PubMed ID: 25588420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion Index Analysis in Patients Presenting to the Emergency Department Due to Synthetic Cannabinoid Use.
    Yeniocak S
    Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31756995
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Synthetic Cannabinoids on P-Wave Dispersion: An Observational Study.
    Aydin Sunbul E; Sunbul M; Terzi A; Calli S; Koca E; Bilici R; Citak S
    Med Princ Pract; 2016; 25(5):483-7. PubMed ID: 27287436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid pharmacology.
    Dewey WL
    Pharmacol Rev; 1986 Jun; 38(2):151-78. PubMed ID: 3529128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.